• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸结石形成者和非胱氨酸结石形成者中的胱氨酸结晶尿症及尿液饱和度

Cystine crystalluria and urinary saturation in cystine and non-cystine stone formers.

作者信息

Labeeuw M, Gerbaulet C, Pozet N, Zech P, Traeger J

出版信息

Urol Res. 1981;9(4):163-8. doi: 10.1007/BF00264821.

DOI:10.1007/BF00264821
PMID:7269003
Abstract

It has been suggested recently that the first step in the formation of calcium oxalate stones appears to be crystallisation. This step is said to depend on the state of saturation of the urine. This hypothesis was checked in cystine stone formers. Cystine crystalluria was found in 83% of 24 urine samples from cystine stone formers (CSF) but in one of the 400 control samples and appears to be a good guide in the diagnosis of cystine lithiasis. Urinary cystine saturation was constantly higher in CSF than in non-cystine stone formers (NCSF) who exhibited undersaturated urine with respect to cystine. There was almost no overlap between these 2 groups. Crystals were never found in undersaturated urine and were always present when the saturation was above 1. There appears to be a good correlation between the level of urinary saturation and the presence of crystalluria and there is no need for any additional factor such as a defective inhibitor. The study underlines the limits of a therapeutic regimen of a high fluid intake and alkalinisation of the urine.

摘要

最近有人提出,草酸钙结石形成的第一步似乎是结晶。据说这一步取决于尿液的饱和状态。在胱氨酸结石患者中对这一假设进行了验证。在24例胱氨酸结石患者(CSF)的尿液样本中,83%发现有胱氨酸结晶尿,但在400例对照样本中仅有1例出现,这似乎是诊断胱氨酸结石的一个很好的指标。CSF患者的尿胱氨酸饱和度始终高于非胱氨酸结石患者(NCSF),后者的尿液相对于胱氨酸呈不饱和状态。这两组之间几乎没有重叠。在不饱和尿液中从未发现晶体,而当饱和度高于1时晶体总是存在。尿饱和度水平与结晶尿的存在之间似乎有很好的相关性,并且不需要任何额外的因素,如缺陷抑制剂。该研究强调了高液体摄入量和尿液碱化治疗方案的局限性。

相似文献

1
Cystine crystalluria and urinary saturation in cystine and non-cystine stone formers.胱氨酸结石形成者和非胱氨酸结石形成者中的胱氨酸结晶尿症及尿液饱和度
Urol Res. 1981;9(4):163-8. doi: 10.1007/BF00264821.
2
Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.胱氨酸尿症与其他形式肾结石相比,肾功能降低及治疗的益处。
BJU Int. 2006 Jun;97(6):1285-90. doi: 10.1111/j.1464-410X.2006.06169.x.
3
Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine.胱氨酸:正常未稀释人尿液中草酸钙晶体生长和聚集的促进剂。
J Urol. 2002 Jan;167(1):317-21. doi: 10.1016/s0022-5347(05)65461-4.
4
Durability of the medical management of cystinuria.胱氨酸尿症药物治疗的持久性。
J Urol. 2003 Jan;169(1):68-70. doi: 10.1016/S0022-5347(05)64037-2.
5
Cystine crystal volume determination: a useful tool in the management of cystinuric patients.胱氨酸晶体体积测定:胱氨酸尿症患者管理中的一项有用工具。
Urol Res. 2003 Jul;31(3):207-11. doi: 10.1007/s00240-003-0319-0. Epub 2003 May 14.
6
Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.结石患者和正常受试者肾尿与膀胱尿中草酸钙结晶尿的研究。
Urol Int. 1998;60(1):41-6. doi: 10.1159/000030201.
7
Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.胱氨酸结石患者与非胱氨酸结石患者的健康相关生活质量(HRQoL)比较。
Urolithiasis. 2014 Feb;42(1):53-60. doi: 10.1007/s00240-013-0621-4. Epub 2013 Nov 20.
8
Cystine Stone Formers Have Impaired Health-Related Quality of Life Compared with Noncystine Stone Formers: A Case-Referent Study Piloting the Wisconsin Stone Quality of Life Questionnaire Among Patients with Cystine Stones.与非胱氨酸结石患者相比,胱氨酸结石患者的健康相关生活质量受损:一项在胱氨酸结石患者中试用威斯康星结石生活质量问卷的病例对照研究。
J Endourol. 2017 Apr;31(S1):S48-S53. doi: 10.1089/end.2016.0564. Epub 2016 Nov 8.
9
Cystine stones: the impact of new treatment.胱氨酸结石:新疗法的影响
Br J Urol. 1991 Sep;68(3):234-9. doi: 10.1111/j.1464-410x.1991.tb15313.x.
10
Can the Presence of Crystalluria Predict Stone Formation in Patients with Cystinuria?结晶尿的出现能否预测胱氨酸尿症患者的结石形成?
J Endourol. 2016 May;30(5):609-14. doi: 10.1089/end.2015.0692.

本文引用的文献

1
TREATMENT OF CYSTINURIA.胱氨酸尿症的治疗
Br Med J. 1965 Feb 13;1(5432):403-8.
2
Observations on the analysis of ten thousand urinary calculi.一万例尿结石分析观察报告
J Urol. 1962 Oct;88:545-62. doi: 10.1016/S0022-5347(17)64842-0.
3
Studies on the treatment of cystinuria.胱氨酸尿症的治疗研究。
Br J Urol. 1955 Dec;27(4):317-32. doi: 10.1111/j.1464-410x.1955.tb03486.x.
4
Phenotypes and genotypes in cystinuria.胱氨酸尿症的表型与基因型
Ann Hum Genet. 1955 Aug;20(1):57-91. doi: 10.1111/j.1469-1809.1955.tb01278.x.
5
The pathogenesis of cystinuria. II. Polarographic studies of the metabolism of sulfur-containing amino-acids.胱氨酸尿症的发病机制。II. 含硫氨基酸代谢的极谱研究。
J Clin Invest. 1954 Sep;33(9):1216-26. doi: 10.1172/JCI102996.
6
Urinary urate and uric acid relative saturation in normouricuric calcium oxalate stone formers with normal urinary calcium oxalate saturation.
Adv Exp Med Biol. 1980;122A:87-92. doi: 10.1007/978-1-4615-9140-5_14.
7
Cystinuria: biochemical evidence for three genetically distinct diseases.胱氨酸尿症:三种基因不同疾病的生化证据。
J Clin Invest. 1966 Mar;45(3):365-71. doi: 10.1172/JCI105351.
8
Cystinuria--report of 56 cases.
Urol Int. 1965;20(3):154-62. doi: 10.1159/000279372.
9
Activity products in stone-forming and non-stone-forming urine.形成结石和不形成结石的尿液中的活性产物。
Clin Sci. 1968 Jun;34(3):579-94.
10
Factors involved in crystal formation in cystinuria. In vivo and in vitro crystallization dynamics and a simple, quantitative colorimetic assay for cystine.胱氨酸尿症中晶体形成的相关因素。体内和体外结晶动力学以及一种简单的胱氨酸定量比色测定法。
J Urol. 1971 Jul;106(1):106-10. doi: 10.1016/s0022-5347(17)61236-9.